Needham & Company
-
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
-
Axonics Modulation Technologies (AXNX) Prices 3.5M Share Upsized Common Offering at $50/Sh
-
Axonics® Announces Upsize and Pricing of Public Offering of Common Stock
-
Axonics Modulation Technologies (AXNX) to Offer $150M in Common Stock
-
Axonics® Announces Proposed Public Offering of Common Stock
-
Axonics Modulation Technologies Inc. (AXNX) PT Raised to $66 at Needham & Company
-
Axonics Modulation Technologies Inc. (AXNX) PT Raised to $62 at Needham & Company
-
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
-
Axonics Modulation Technologies Inc. (AXNX) Prices 4M Share Common Offering at $32.50/Sh
-
Axonics® Announces Pricing of Public Offering of Common Stock
-
Axonics Modulation Technologies Inc. (AXNX) Announces $100M Proposed Public Offering of Common Stock
-
Axonics® Announces Proposed Public Offering of Common Stock
-
Medtech Visionary Geoff Pardo, Gilde Healthcare Named New Medtech Talk Podcast Host
-
Axonics® to Present at the Needham Healthcare Conference
-
Companies with NDRs 11/21
-
Axonics Modulation Technologies Inc. (AXNX) Investors Should Focus on the Launch not the Miss - Needham
-
Axonics Modulation Technologies Inc. (AXNX) PT Raised to $48 at Needham & Company
-
Needham & Company Starts Axonics Modulation Technologies Inc. (AXNX) at Buy
-
Axonics® to Present at the Needham Healthcare Conference